Advanz Pharma Corp. buy melinda
Start price
15.08.17
/
50%
€384.00
Target price
19.12.17
€450.00
Performance (%)
-45.31%
End price
19.12.17
€210.00
Summary
This prediction ended on 19.12.17 with a price of €210.00. Massive losses of -45.31% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Advanz Pharma Corp. | - | - | - | - |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% | 53.734% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% | 104.329% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% | 73.793% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% | 72.579% |
Comments by melinda for this prediction
In the thread Advanz Pharma Corp diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Advanz Pharma Corp.
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€346.37
15.08.17
15.08.17
€405.90
19.12.17
19.12.17
-45.31%
19.12.17
19.12.17
Advanz Pharma Corp.
Start price
Target price
Perf. (%)
€2,570.4
12.08.16
12.08.16
€3,264.0
13.02.17
13.02.17
-74.52%
13.02.17
13.02.17


